Plenary Session 2: CrisprCas9 Therapy for Sickle Cell Diseases: How Do We Go from Discovery to Equitable Availability of Gene Therapy for All? (Obiageli Eunice Nnodu, Nigeria)

14 Apr 2024 11 a.m. 12 p.m.
Hall A
AgnesFogo Chairperson United States
GuillermoRosa Diez Chairperson Hospital Italiano de Buenos Aires; Argentinean Society of Nephrology; Latinoamerican Society of Nephrology and Hypertension; International Society of NephrologyArgentina
Add to My Schedule

Plenary Session 2: CrisprCas9 Therapy for Sickle Cell Diseases: How Do We Go from Discovery to Equitable Availability of Gene Therapy for All? (Obiageli Eunice Nnodu, Nigeria)

Time Session
11:05 a.m.
11:10 a.m.
My Story
VictoriaGray Speaker vwright_03@yahoo.comUnited States
11:10 a.m.
11:50 a.m.
CrisprCas9 Therapy for Sickle Cell Diseases: How Do We Go from Discovery to Equitable Availability of Gene Therapy for All? Hugh de Wardener Lecture
Obiageli EuniceNnodu Speaker oennodu@gmail.comUniversity of AbujaNigeria